S&P 500: 681.75 +0.1% NASDAQ 100: 601.92 +0.2% Dow Jones: 495.28 +0.1%

Renaissance Technologies’s CLBT Holdings & Trades

First Buy
Q4 2022
Duration Held
13 Quarters
Largest Add
Q1 2025
+979,900 Shares
Current Position
2.49 M Shares
$44.98 M Value

Renaissance Technologies's CLBT Position Overview

Renaissance Technologies (via Renaissance Technologies LLC) currently holds 2.49 M shares of Cellebrite DI Ltd. (CLBT) worth $44.98 M, representing 0.07% of the portfolio. First purchased in 2022-Q4, this medium-term investment has been held for 13 quarters.

Based on 13F filings, Renaissance Technologies has maintained a strategic position in CLBT, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2025, adding 979,900 shares. Largest reduction occurred in Q4 2025, reducing 407,166 shares.

Analysis based on 13F filings available since 2013 Q2

Renaissance Technologies's Cellebrite DI (CLBT) Holding Value Over Time

Track share changes against reported price movement

Quarterly Cellebrite DI (CLBT) Trades by Renaissance Technologies

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q4 2022 +13,300 New Buy 13,300 $0.00
Q1 2023 +63,300 Add 475.94% 76,600 $0.01
Q2 2023 +120,700 Add 157.57% 197,300 $0.01
Q3 2023 +126,100 Add 63.91% 323,400 $7.65
Q4 2023 +727,756 Add 225.03% 1.05 M $8.66
Q1 2024 -82,056 Reduce 7.81% 969,100 $11.08
Q2 2024 +214,600 Add 22.14% 1.18 M $11.95
Q3 2024 +330,800 Add 27.95% 1.51 M $16.84
Q4 2024 +115,939 Add 7.66% 1.63 M $22.03
Q1 2025 +979,900 Add 60.10% 2.61 M $19.43
Q2 2025 +76,000 Add 2.91% 2.69 M $16.00
Q3 2025 +215,766 Add 8.03% 2.9 M $18.53
Q4 2025 -407,166 Reduce 14.03% 2.49 M $18.03

Renaissance Technologies's Cellebrite DI Investment FAQs

Renaissance Technologies first purchased Cellebrite DI Ltd. (CLBT) in Q4 2022, acquiring 13,300 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Renaissance Technologies has held Cellebrite DI Ltd. (CLBT) for 13 quarters since Q4 2022.

Renaissance Technologies's largest addition to Cellebrite DI Ltd. (CLBT) was in Q1 2025, adding 2,610,339 shares worth $50.72 M.

According to the latest 13F filing for Q4 2025, Renaissance Technologies's firm, Renaissance Technologies LLC, owns 2,494,939 shares of Cellebrite DI Ltd. (CLBT), valued at approximately $44.98 M.

As of the Q4 2025 filing, Cellebrite DI Ltd. (CLBT) represents approximately 0.07% of Renaissance Technologies's publicly disclosed stock portfolio, making it one of their key holdings.

Renaissance Technologies's peak holding in Cellebrite DI Ltd. (CLBT) was 2,902,105 shares, as reported at the end of Q3 2025.